annual EBITDA:
$69.95M+$77.65M(+1008.05%)Summary
- As of today (September 18, 2025), TMDX annual EBITDA is $69.95 million, with the most recent change of +$77.65 million (+1008.05%) on December 31, 2024.
- During the last 3 years, TMDX annual EBITDA has risen by +$108.44 million (+281.74%).
- TMDX annual EBITDA is now at all-time high.
Performance
TMDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$43.30M+$9.72M(+28.94%)Summary
- As of today (September 18, 2025), TMDX quarterly EBITDA is $43.30 million, with the most recent change of +$9.72 million (+28.94%) on June 30, 2025.
- Over the past year, TMDX quarterly EBITDA has increased by +$26.19 million (+153.10%).
- TMDX quarterly EBITDA is now at all-time high.
Performance
TMDX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$100.30M+$26.19M(+35.34%)Summary
- As of today (September 18, 2025), TMDX TTM EBITDA is $100.30 million, with the most recent change of +$26.19 million (+35.34%) on June 30, 2025.
- Over the past year, TMDX TTM EBITDA has increased by +$59.29 million (+144.59%).
- TMDX TTM EBITDA is now at all-time high.
Performance
TMDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TMDX EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +1008.0% | +153.1% | +144.6% |
3 y3 years | +281.7% | +593.4% | +358.8% |
5 y5 years | +350.4% | +678.3% | +430.1% |
TMDX EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +281.7% | at high | +593.4% | at high | +358.8% |
5 y | 5-year | at high | +281.7% | at high | +484.2% | at high | +354.6% |
alltime | all time | at high | +281.7% | at high | +484.2% | at high | +354.6% |
TMDX EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $43.30M(+28.9%) | $100.30M(+35.3%) |
Mar 2025 | - | $33.58M(+134.4%) | $74.11M(+29.2%) |
Dec 2024 | $69.95M(-1008.0%) | $14.32M(+57.4%) | $57.35M(+16.2%) |
Sep 2024 | - | $9.10M(-46.8%) | $49.34M(+20.3%) |
Jun 2024 | - | $17.11M(+1.7%) | $41.01M(+66.6%) |
Mar 2024 | - | $16.82M(+166.7%) | $24.62M(+242.6%) |
Dec 2023 | -$7.70M(-73.4%) | $6.31M(+719.2%) | $7.18M(-262.1%) |
Sep 2023 | - | $770.00K(+7.2%) | -$4.43M(-54.2%) |
Jun 2023 | - | $718.00K(-217.5%) | -$9.68M(-49.5%) |
Mar 2023 | - | -$611.00K(-88.5%) | -$19.17M(-29.6%) |
Dec 2022 | -$28.96M(-24.8%) | -$5.31M(+18.7%) | -$27.24M(-14.8%) |
Sep 2022 | - | -$4.47M(-49.0%) | -$31.97M(-17.5%) |
Jun 2022 | - | -$8.78M(+1.1%) | -$38.76M(-1.6%) |
Mar 2022 | - | -$8.68M(-13.4%) | -$39.40M(+7.1%) |
Dec 2021 | -$38.49M | -$10.03M(-11.0%) | -$36.78M(+14.2%) |
Sep 2021 | - | -$11.27M(+19.7%) | -$32.22M(+28.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | -$9.42M(+55.3%) | -$25.15M(+8.3%) |
Mar 2021 | - | -$6.06M(+10.9%) | -$23.22M(-6.4%) |
Dec 2020 | -$23.15M(-17.1%) | -$5.47M(+29.9%) | -$24.81M(-10.4%) |
Sep 2020 | - | -$4.21M(-43.8%) | -$27.68M(-8.9%) |
Jun 2020 | - | -$7.49M(-2.1%) | -$30.38M(+0.2%) |
Mar 2020 | - | -$7.65M(-8.3%) | -$30.31M(+6.8%) |
Dec 2019 | -$27.93M(+38.1%) | -$8.34M(+20.7%) | -$28.38M(+8.4%) |
Sep 2019 | - | -$6.91M(-6.8%) | -$26.18M(+13.8%) |
Jun 2019 | - | -$7.42M(+29.7%) | -$23.00M(+47.6%) |
Mar 2019 | - | -$5.72M(-6.9%) | -$15.59M(+57.9%) |
Dec 2018 | -$20.23M(+6.0%) | -$6.14M(+64.8%) | -$9.87M(+22.4%) |
Sep 2018 | - | -$3.73M(-14.1%) | -$8.06M(-9.3%) |
Dec 2017 | -$19.09M(-15.8%) | - | - |
Dec 2017 | - | -$4.34M(-4.7%) | -$8.89M(+95.3%) |
Sep 2017 | - | -$4.55M | -$4.55M |
Dec 2016 | -$22.66M | - | - |
FAQ
- What is TransMedics Group, Inc. annual EBITDA?
- What is the all time high annual EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. annual EBITDA year-on-year change?
- What is TransMedics Group, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?
- What is TransMedics Group, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for TransMedics Group, Inc.?
- What is TransMedics Group, Inc. TTM EBITDA year-on-year change?
What is TransMedics Group, Inc. annual EBITDA?
The current annual EBITDA of TMDX is $69.95M
What is the all time high annual EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high annual EBITDA is $69.95M
What is TransMedics Group, Inc. annual EBITDA year-on-year change?
Over the past year, TMDX annual EBITDA has changed by +$77.65M (+1008.05%)
What is TransMedics Group, Inc. quarterly EBITDA?
The current quarterly EBITDA of TMDX is $43.30M
What is the all time high quarterly EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high quarterly EBITDA is $43.30M
What is TransMedics Group, Inc. quarterly EBITDA year-on-year change?
Over the past year, TMDX quarterly EBITDA has changed by +$26.19M (+153.10%)
What is TransMedics Group, Inc. TTM EBITDA?
The current TTM EBITDA of TMDX is $100.30M
What is the all time high TTM EBITDA for TransMedics Group, Inc.?
TransMedics Group, Inc. all-time high TTM EBITDA is $100.30M
What is TransMedics Group, Inc. TTM EBITDA year-on-year change?
Over the past year, TMDX TTM EBITDA has changed by +$59.29M (+144.59%)